US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.48

+0.22000.56%

Volume:25.33K

Turnover:995.37K

Market Cap:258.59M

PE:- -

High:39.56

Open:39.05

Low:39.05

Close:39.26

52wk High:41.49

52wk Low:22.18

Shares:6.55M

Float Shares:6.55M

Volume Ratio:0.46

T/O Rate:0.39%

Dividend:0.28

Dividend Rate:0.72%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS

Celcuity To Participate in Upcoming Investor Conferences

Moderna to Present at Morgan Stanley Global Healthcare Conference

Satellos to Participate in Upcoming Investor Conferences

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Revolution Medicines Signs Long-Term Headquarters Lease Agreement

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUE

Simply Wall St.

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease

Incyte Reaches CMS Pact on Jakafi Medicaid Pricing

NeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-210

Incyte - Expects Exemption from Future CMS Pricing Mandates Including Guard and Globe - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IDNA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":39.48,"timestamp":1788278665745,"preClose":39.26,"halted":0,"volume":25326,"delay":0,"changeRate":0.005603667855323456,"floatShares":6550000,"shares":6550000,"eps":0,"marketStatus":"Trading","change":0.22,"latestTime":"09-01 12:04:45 EDT","open":39.05,"high":39.56,"low":39.05,"amount":995367.339918,"amplitude":0.01299,"askPrice":39.55,"askSize":60,"bidPrice":39.35,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":39.26,"sharesOutstanding":5100000,"nav":39.224094,"aum":256917815.7,"dividendRate":0.007166,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.96,"preClose":39.26,"latestTime":"09:08 EDT","volume":3,"amount":119.110005,"timestamp":1788268100857,"change":0.7,"changeRate":0.01783,"amplitude":0.018085},"postHourTrading":{"tag":"盘后","latestPrice":39.26,"preClose":39.26,"latestTime":"19:30 EDT","volume":54,"amount":2127.06,"timestamp":1788219002774,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.457969,"impliedVol":0.1209,"impliedVolPercentile":0.2143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6550000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.457969,"shares":6550000,"dividePrice":0.2829,"high":39.56,"amplitude":0.01299,"preClose":39.26,"low":39.05,"week52Low":22.18,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":39.48,"committee":0.666667,"eps":0,"divideRate":0.007166,"volume":25326,"delay":0,"ttmEps":0,"open":39.05,"prevYearClose":26.19,"prevWeekClose":39.29,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":41.48,"twentyDayClose":32.9055,"sixtyDayClose":29.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664500918","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2664500918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664500918?lang=en_us&edition=fundamental","pubTime":"2026-09-02 00:00","pubTimestamp":1788278413,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeModerna, Inc.MRNA.OQ+6.2%Mosaic CoMOS.N+4.2%Dollar Tree IncDLTR.OQ+3.8%Corteva, Inc.CTVA.N+3.6%Dollar General CorpDG.N+3.4%Bottom PerformersPercent ChangeAxon Enterprise, Inc.AXON.OQ-9.1%CrowdStrike Holdings, Inc.CRWD.OQ-6.9%Cadence Design Systems, Inc.CDNS.OQ-5.6%Ciena CorporationCIEN.N-5.4%Palo Alto Networks, Inc.PANW.OQ-5.3%As of 12:00 p.m., the S&P 500.SPXlost 25.96 points, or 0.34%, to 7,660.18 and had posted 7 new 52-week highs and 10 new lows.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL8N44T1PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VEGI","PBJ","LGHT","CDNS","AIFD","CRWD","KROP","CIEN","CIEG","IE00B5949003.HKD","AXUP","XAR","CRWL","PANG","RSPS","MRNY","AIPI","CRWC","CIEX","XTL","IHAK","AXON","EYES","WCLD","LU0724618433.USD","BUG","CIBR","WCBR","GNOM","WDNA","PSWD","IDNA","IGV","CLOD","FTAG","PALD","FOTO","HAKY","GUNZ","MRNX","DG","PYZ","CTVA","SPAM","DLTR","MRNA","PANW","CDNG","PALU","MOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854756","title":"Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854756","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854756?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:51","pubTimestamp":1788270662,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  has completed its acquisition of Crinetics Pharmaceuticals , Vertex said on Tuesday.Following the acquisition's closing, Jonathan Poole will take over Vertex's chief financial officer role, effective Jan. 1, Vertex said. Poole currently serves as Vertex's senior vice president for finance, the company said.Charles Wagner, chief operating and financial officer of Vertex, will expand his COO role to head Crinetics' integration, effective immediately, Vertex said.Price: 549.07, Change: +4.55, Percent Change: +0.83","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","IE0002270589.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","LU1069344957.HKD","LU1674673691.USD","LU2236285917.USD","BK4139","GNMX","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD","TBXU","VRTX","LU1559883803.SGD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4567","PBE","CRNX","LU0432979614.USD","BIB","IE00B19Z3581.USD","LU0320765992.SGD","IE00B894F039.SGD","VERX","LU0289739699.SGD","LU0757428866.USD","LU1430594728.SGD","LU0079474960.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","BK4533","LU0058720904.USD","LU0566484027.USD","IBB","IBBQ","LU1778281490.HKD","IDNA","LU2089984988.USD","LU0234570918.USD","LU2468319806.SGD","BBH","LU2362541273.HKD","LU2456880835.USD","LU1093756325.SGD","LU0889565916.HKD","LU0417517546.SGD","IE0009355771.USD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664144854","title":"Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664144854","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664144854?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:25","pubTimestamp":1788269142,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) announced the successful completion of the acquisition of Crinetics Pharmaceuticals (CRNX). Vertex also announced the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","LU2362541513.USD","PBE","LU0079474960.USD","IE00B19Z9P08.USD","VERX","LU1093756325.SGD","CRNX","LU0889565916.HKD","IDNA","LU0432979614.USD","SGXZ57979304.SGD","SG9999013999.USD","LU1093756168.USD","LU1674673428.USD","LU2468319806.SGD","IE00B2B36J28.USD","SG9999001176.USD","IE00BJT1NW94.SGD","BK4007","LU0109394709.USD","IBBQ","BIB","LU0058720904.USD","BBH","IE0002141913.USD","IE00B4R5TH58.HKD","LU2236285917.USD","LU2462157665.USD","VRTX","LU0823416689.USD","LU2237438978.USD","IE00B894F039.SGD","LU1430594728.SGD","BK4567","LU0320765992.SGD","LU1035775433.USD","LU0757428866.USD","LU0256863811.USD","IBB","LU2089984988.USD","LU0061475181.USD","BK4023","LU0417517546.SGD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","TBXU","LU1815336091.USD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851485","title":"Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851485","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851485?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:04","pubTimestamp":1788267895,"startTime":"0","endTime":"0","summary":"Vertex names Jonathan Poole CFO effective Jan. 1, 2027Vertex expanded its executive leadership team following the close of its Crinetics acquisition on Sept. 1, 2026.Charles Wagner, EVP and chief oper","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4Tv8z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","EVLO","LU0289739699.SGD","IE0009355771.USD","BK4599","GNCAQ","BK4532","IBB","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","PJP","SGXZ57979304.SGD","LU2468319806.SGD","LU2089984988.USD","SG9999013999.USD","AMGN","VRTX","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU2462157665.USD","BK4139","BBH","IBBQ","IE00B2B36J28.USD","LU1585245621.USD","LU1093756325.SGD","IE00B19Z9P08.USD","TBXU","BK4581","LU1093756168.USD","LU2362540622.SGD","LU0234570918.USD","LU0061475181.USD","LU2362541273.HKD","LU0079474960.USD","LU0823416689.USD","GNMX","LU1023059063.AUD","LU0432979614.USD","BK4588","SG9999001176.USD","LU0109394709.USD","BK4567","LU1778281490.HKD","BIB","LU1035775433.USD","BK4566","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664117851","title":"Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2664117851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664117851?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:03","pubTimestamp":1788267780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA44TDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","IE00B19Z9P08.USD","IE0002270589.USD","LU0320765992.SGD","BIB","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBB","LU2236285917.USD","SG9999001176.SGD","GNMX","BK4585","IBBQ","BK4567","BK4139","LU1674673691.USD","SGXZ57979304.SGD","IE00B2B36J28.USD","IDNA","BK4588","LU1674673428.USD","IE0002141913.USD","IE00BZ9MQY76.HKD","TBXU","LU0823416689.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","LU1430594728.SGD","IE00B19Z9Z06.USD","VRTX","LU2417539215.USD","LU2468319806.SGD","LU0079474960.USD","LU1778281490.HKD","LU0234570918.USD","LU0432979614.USD","BK4532","LU1035775433.USD","LU2362541513.USD","BBH","LU1093756168.USD","LU2456880835.USD","IE0009355771.USD","LU1585245621.USD","IE00B19Z3581.USD","LU2237438978.USD","LU2324357040.USD","PBE","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851222","title":"Celcuity To Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851222","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851222?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:30","pubTimestamp":1788265800,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354143/0/en/celcuity-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIB","IDNA","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083853","title":"Moderna to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083853","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083853?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:06","pubTimestamp":1788260801,"startTime":"0","endTime":"0","summary":"Moderna to present at Morgan Stanley Global Healthcare ConferenceModerna will present at the Morgan Stanley Global Healthcare Conference on Sept. 14, 2026 at 10:00 a.m. ET.It will also present at the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8XX49W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LU2264538146.SGD","LU2357305700.SGD","LU1989772923.USD","GNOM","BK4533","LU1244550577.SGD","BK4581","LU1791710582.SGD","MRNX","LU1989772840.SGD","LU1791710400.SGD","LGHT","LU2347655156.SGD","BK4516","LU2111349929.HKD","LU1720051017.SGD","WDNA","BK4504","KBWB","LU0106261372.USD","LU0106831901.USD","LU0795875086.SGD","LU0267386448.USD","LU2028103732.USD","IE00B775SV38.USD","LU0158827948.USD","LU0528227936.USD","LU0912757837.SGD","LU0557290698.USD","BK4548","LU0225283273.USD","BK4585","IE00BZ1G4Q59.USD","LU0320765646.SGD","LU0795875169.SGD","LU1732799900.SGD","LU0390134368.USD","LU1064131342.USD","MRNA","LU1720051108.HKD","LU1988902786.USD","LU2023251221.USD","MRNY","BK4588","BK4501","LU1548497426.USD","IAI","LU0882574139.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664085583","title":"Satellos to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664085583","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664085583?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"TORONTO, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative mus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353948/0/en/satellos-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSLE","NVIB","HYLG","MEDX","IDNA","BK4139","GDOC","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853142","title":"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853142","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853142?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:50","pubTimestamp":1788259807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LL...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-incyte-incy-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-incyte-incy-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2471134796.USD","LU1127390331.HKD","IE00BFTCPJ56.SGD","LU0006306889.USD","LU0106261372.USD","LU0943347566.SGD","LU1979441026.SGD","LU2089984988.USD","LU0882574139.USD","LU0823434583.USD","SGXZ81514606.USD","SG9999014914.USD","OZEM","LU2361044949.HKD","LU2468319806.SGD","BK4588","LU2461242641.AUD","LU2168564222.USD","LU0234572021.USD","LU2462591350.SGD","LU1974910355.USD","LU2237438978.USD","LU2552382058.USD","LU2237443622.USD","LU2271345857.HKD","LU2750360641.GBP","LLY","LU2236285917.USD","LU0256863811.USD","LU2168563687.JPY","LU0058720904.USD","IE00BKPKM429.USD","GDOC","LU1267930730.SGD","LU2211815571.USD","LU0079474960.USD","HRTS","LU1720051108.HKD","LU2264538146.SGD","TRUH","LU0158827948.USD","LU2324357040.USD","LU2028103732.USD","IE00BK4W5L77.USD","BK4139","LU0316494557.USD","IE0004445015.USD","LU0683600562.USD","SG9999014906.USD","LU2111349929.HKD","IXJ","LU0672654240.SGD","SGXZ31699556.SGD","IE00BJT1NW94.SGD","LU1035775433.USD","SGXZ51526630.SGD","LU0353189763.USD","LU0889565916.HKD","PJP","GB00BDT5M118.USD","LU2023251221.USD","SG9999018865.SGD","LU2087625088.SGD","LU0385154629.USD","LU1548497426.USD","LU0708995401.HKD","LU0266013472.USD","LU2168564495.EUR","IE0001KFT4U8.USD","LU0203201768.USD","LU0323591593.USD","LU0882574055.USD","LU1868836914.USD","LU2756315318.SGD","LU1917777945.USD","LU1551013425.SGD","LU1623119135.USD","LU1064131342.USD","LU1023059063.AUD","LU2063271972.USD","BK4007","LU2471134952.CNY","LU1868837300.USD","LU2357305700.SGD","LU1629891620.HKD","IE0002141913.USD","LU2361045086.USD","LU2361044865.SGD","IE00BJLML261.HKD","IE00B1XK9C88.USD","IE00BWXC8680.SGD","LU1989771016.USD","FTXH","LU0820562030.AUD","LU1057294990.SGD","PPH","LLYZ","LU2237443465.HKD","LU0471298777.SGD","ELIS","IE00BJJMRZ35.SGD","LU0238689110.USD","LU0320765059.SGD","LU2237443382.USD","IE00B1BXHZ80.USD","LU1988902786.USD","IMUX","SG9999014880.SGD","LU1145028129.USD","LU0640476718.USD","SG9999013999.USD","LU2552382132.HKD","LU0096364046.USD","LU1868837136.USD","LU0823416689.USD","SG9999018857.SGD","BK4534","LU2112291526.USD","LU2602419157.SGD","JDOC","LU0109391861.USD","LU2237443978.SGD","WDNA","LU1868836757.USD","LU1069344957.HKD","LU2023250330.USD","LU2746668461.USD","IE00BN29S564.USD","LU2491049909.HKD","LU0061475181.USD","FHLC","LLYX","LU1291159041.SGD","IE00B4R5TH58.HKD","LU2108987350.USD","LU0689472784.USD","SG9999015978.USD","LU1093756168.USD","CANC","LU0417517546.SGD","LU0320765992.SGD","LU0114720955.EUR","LU1804176565.USD","CURE","LU0353189680.USD","LU1366192091.USD","RXL","SG9999015945.SGD","LU2456880835.USD","LU2213496289.HKD","LU0820561818.USD","LU2491050071.SGD","LU0158827781.USD","LU0964807845.USD","IE00BFSS8Q28.SGD","LU0289739699.SGD","LU2471134879.HKD","BK4550","IE00BK4W5M84.HKD","LU0225283273.USD","IE0005OL40V9.USD","LU1323610961.USD","IDNA","LU2491050154.USD","IE00BKDWB100.SGD","LU2896262040.SGD","SG9999015986.USD","LU2746668974.SGD","LU1814569148.SGD","LU2237443895.HKD","SGXZ99366536.SGD","LU2462157665.USD","VHT","LU0256863902.USD","LU0432979614.USD","TMED","IE00B2B36J28.USD","LU2552382215.SGD","LU2360106947.USD","LU2023250504.SGD","LU2168564149.EUR","LU0471298694.HKD","LU0787776722.HKD","SGXZ57979304.SGD","LU0786609619.USD","LU2750360997.AUD","LU0466842654.USD","BK4532","LU0198837287.USD","LU0354030511.USD","IE00BFSS7M15.SGD","IE00B4JS1V06.HKD","MEDI","SG9999001176.USD","LLII","SG9999015952.SGD","MEDX","LU0174119429.USD","LU1983299246.USD","LU2089283258.USD","BK4516","LU1868836591.USD","LU2471134523.USD","LU0345770993.USD","LU1093756325.SGD","SG9999001176.SGD","ELIL","BK4599","AGNG","LU2237443549.SGD","IYH","LU0456855351.SGD","LU2089284900.SGD","LU0094547139.USD","LU0354030438.USD","LU1280957306.USD","SG9999017495.SGD","IHE","LU1691799644.USD","LU0820561909.HKD","SG9999014898.SGD","LU2417539215.USD","IE00B775H168.HKD","LU1061106388.HKD","LU1720051017.SGD","LU2168564065.EUR","LU0109394709.USD","LU1551013342.USD","THNR","IE00BJJMRY28.SGD","LU0345770308.USD","BK4533","IE0009355771.USD","LU0133085943.USD","IE00B7KXQ091.USD","LU0823434740.USD","LU1232071149.USD","BK4581","LU0097036916.USD","LU2106854487.HKD","LU2265009873.SGD","LU0210536198.USD","IE00BJJMRX11.SGD","LU1712237335.SGD","INCY","LU0122379950.USD","LU0203202063.USD","LU2756315664.SGD","IE0004445239.USD","ILDR","BK4585","MHIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765489.SGD","BMED","IE00B2B36J28.USD","IE0002141913.USD","SYNB","TBXU","LU0211331839.USD","IBBQ","IE00BFTCPJ56.SGD","NVIB","PPH","BK4007","IE00B4R5TH58.HKD","LU0070302665.USD","HYLG","IE0009355771.USD","LU0208291251.USD","BK4588","CNCR","LFSC","IE00BJT1NW94.SGD","NVS","IBB","GDOC","BK4532","BK4585","FBT","GNOM","IE00BJJMRZ35.SGD","BK4578","MEDX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664538548","title":"Revolution Medicines Signs Long-Term Headquarters Lease Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664538548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664538548?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:29","pubTimestamp":1788258558,"startTime":"0","endTime":"0","summary":"Revolution Medicines ( ($RVMD) ) has provided an announcement. On August 27, 2026, Revolution Medicines agreed to lease four buildings totaling abo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/revolution-medicines-signs-long-term-headquarters-lease-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/revolution-medicines-signs-long-term-headquarters-lease-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","PTH","IE0009355771.USD","IDNA","RVMD","IE0009354923.USD","IE0002141913.USD","IE00B2B36J28.USD","LU0889565916.HKD","CANC","IE00B4R5TH58.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","BK4139","IE00BJT1NW94.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287830","title":"Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:40","pubTimestamp":1788255621,"startTime":"0","endTime":"0","summary":"Goldman Sachs analysts added Vertex Pharmaceuticals (VRTX) to the firm’s US Conviction List as part of its monthly update. Goldman believes Vertex ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2236285917.USD","IE00BSNM7G36.USD","IE00BZ9MQY76.HKD","PBE","IE0002141913.USD","BK4504","LU2471134952.CNY","LU2362541273.HKD","IE00BFTCPJ56.SGD","LU1868836914.USD","IBBQ","LU0345770993.USD","LU2362540622.SGD","BIB","LU1778281490.HKD","LU0432979614.USD","LU0757428866.USD","IE00BJT1NW94.SGD","LU2471134796.USD","LU1430594728.SGD","LU2237443895.HKD","LU1815336091.USD","LU0417517546.SGD","IE0004091025.USD","IE0002270589.USD","LU2237443382.USD","VERX","IBB","LU1668664300.SGD","LU1035775433.USD","IE00B19Z3581.USD","LU1093756325.SGD","IE00B2B36J28.USD","LU1894683264.USD","IE00B894F039.SGD","BK4127","IDNA","LU0106831901.USD","LU0868494708.USD","BBH","LU2471134879.HKD","LU2362541513.USD","SGXZ57979304.SGD","TBXU","GSX","LU1585245621.USD","VRTX","GNMX","LU2089984988.USD","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883781","title":"Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUE","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883781","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883781?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:22","pubTimestamp":1788250932,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) is in focus after the FDA approved RASONQUE, an oral RAS(ON) inhibitor for adults with metastatic pancreatic adenocarcinoma following prior systemic therapy or for those unsuitable for multiagent regimens.\nRevolution Medicines’ share price is around US$205.57 after a slight pullback over the past week. The 30 day share price return of 9.62% and 90 day share price return of 35.86% sit against a year to date share price return of 160.15%, while the 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-rvmd-could-be-7-below-fair-value-on-fda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-rvmd-could-be-7-below-fair-value-on-fda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1854104046.USD","LU1983260115.SGD","LU0124384867.USD","IE00BZ199S13.USD","LU1720051017.SGD","ONG","BK4585","LU1861220033.SGD","IDNA","LABU","LU0348723411.USD","LU0889565916.HKD","ON","LU1861214812.USD","LU1861219969.SGD","PTH","LU1548497426.USD","LU2357305700.SGD","BK4141","LU1978683503.SGD","BK4605","LU0724618433.USD","BK4588","CANC","LU2360107325.USD","LU1720051108.HKD","BK4139","IE0009355771.USD","BK4512","IE00BJJMRZ35.SGD","LU2298322129.HKD","RVMD","IE0002141913.USD","LU1854103824.USD","IE0009354923.USD","LU0109394709.USD","IE00BFMHRM44.USD","IE00B2B36J28.USD","ONX","IE00BD6J9T35.USD","IE00BFTCPJ56.SGD","BBH","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU1861215975.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664836115","title":"Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664836115","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664836115?lang=en_us&edition=fundamental","pubTime":"2026-09-01 14:51","pubTimestamp":1788245470,"startTime":"0","endTime":"0","summary":"TradingKey - In August 2026, the upward momentum in US stocks broadened significantly. Moderna (MRNA) topped the S&P 500 constituents with a 156% gain, surging 375.9% year-to-date. Palantir (PLTR) followed closely behind, rising 51.5% in August, while enterprise software stocks as a whole extended their previous recovery.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262143172-top-10-best-performing-us-stocks-august-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350502.SGD","BK4551","BK4561","BK4532","LU1366333091.USD","LU2264538146.SGD","LU0648001328.SGD","PLTW","LU2271345857.HKD","LU0345781412.USD","LU2063271972.USD","BK4503","LU1823568750.SGD","LU1496350171.SGD","LU1430597077.USD","BK4566","LU0823434740.USD","COWG","LU0980610538.SGD","FSMD","LU1861559042.SGD","LU2362541273.HKD","LU1923622614.USD","LU2265009873.SGD","LU1803068979.SGD","BK4134","SNDQ","BK4023","LU0724618789.USD","LU0130103400.USD","LU0265550946.USD","LU1223082519.USD","LU2247934214.USD","LU0124676726.USD","LU0170899867.USD","SG9999001143.SGD","LU1153585028.USD","SPLTRmain","LU2433249047.HKD","LU0011850046.USD","SNXX","LGHT","LU1988902786.USD","LU1064131342.USD","BK4528","LU0496367417.USD","LU0742534661.SGD","LU1267930813.SGD","PLTU","LU1201861249.SGD","LU0820562030.AUD","LU0265550359.USD","LU0289961442.SGD","LU0289739699.SGD","LU1235294995.USD","LU0557290698.USD","LU2362541513.USD","SMCY","LU0316494557.USD","LU0109392836.USD","LU2089283258.USD","LU0300736062.USD","BK4598","LU0963586101.USD","BK4527","LU2125909916.SGD","LU1720051108.HKD","LU2286300806.USD","BK4579","PTF","BK4613","LU1917777945.USD","LU0127658192.USD","OPTZ","BK4504","LU0300736492.USD","DISK","IE00B19Z8X17.USD","LU2517655028.SGD","NEMG","PLTA","SHLD","GNOM","SMCZ","LU0130102774.USD","SMYY","IE00B19Z8W00.USD","BK4534","PLOO","LU0238689110.USD","LU0211327993.USD","NWMX","LU0348723411.USD","BK4585","LU1791710582.SGD","BK4588","LU2125909247.SGD","LU0612318385.USD","IDNA","LU2023251221.USD","CRMG","LU2517655291.USD","LU1116320737.USD","PLTI","LU1046421795.USD","BK4538","LU1951200564.SGD","IE0002270589.USD","LU0345780281.USD","LU0187121727.USD","LU2106854487.HKD","BK4139","LU0353189763.USD","CLOD","LU2125909593.SGD","MRNY","LU0314104364.USD","BK4607","LU2244417387.USD","BK4568","LU0128525689.USD","LU1720051017.SGD","LU0320765059.SGD","LU2756315318.SGD","FCUS","IE00BZ1G4Q59.USD","LU1989764664.SGD","LU1551013425.SGD","NOW","GDX","LU1951198990.SGD","SCHM","BK4547","LU0158827781.USD","SGDM","NOWL","LU1814569148.SGD","PLTD","LU1989764748.USD","GUNZ","LU2361045086.USD","LU0057025933.USD","LU0058720904.USD","LU1551013342.USD","PLTR","LU2498475776.HKD","LU1861220033.SGD","LU1923622291.USD","SNDC","LU0289739343.SGD","LU0689472784.USD","IGV","BK4501","LU0158827948.USD","IE00B19Z3B42.SGD","PLTZ","LU2111349929.HKD","AIPI","LU1883866441.USD","IE00BMPRXN33.USD","LU0130518102.USD","IE00B19Z9505.USD","SNDK","LU0792757196.USD","LU0267386448.USD","LU0266512473.USD","SMCL","BK4505","LU0310800965.SGD","SMCX","LU2023250843.SGD","PLTG","LU0006306889.USD","BK4608","BK4581","LU1267930730.SGD","BK4548","LU0672654240.SGD","VEEV","LU0642271901.SGD","LU0157215616.USD","BK4570","LU2756315664.SGD","LU2517655374.HKD","LU0354030511.USD","LU2087625088.SGD","LU1223082196.USD","LU0353189680.USD","LU0345780950.USD","LU0211328371.USD","EKG","LU0048573561.USD","LU0788109121.HKD","LU1974910355.USD","LU2361044865.SGD","MRNX","BK4535","LU2543165471.USD","LU2361044949.HKD","PLTY","SMCI","NOWX","SCHA","LU0472753341.HKD","LU2461242641.AUD","IE00BJTD4V19.USD","IE00BMPRXR70.SGD","LU1861558580.USD","LU0154245756.USD","LU1280957306.USD","LU0820561909.HKD","BK4167","LU0107464264.USD","LU1023059493.AUD","IE00BQXX3C00.GBP","SNDU","CNAV","LU0053671581.USD","LU0511384066.AUD","LU1989772923.USD","LU2357305700.SGD","LU0823434583.USD","SMCC","QQQG","LU2023250504.SGD","LU2236285917.USD","LU0640476718.USD","LU0278409577.USD","LU0788108826.HKD","LU0889566641.SGD","FMTL","IE00B19Z9P08.USD","LU1267930490.SGD","LU0081259029.USD","LU0130517989.USD","BK4533","LU0109391861.USD","BK4170","LU0330918003.SGD","BK4017","LU0055631609.USD","IE00BKVL7J92.USD","LU0719512351.SGD","NEM","CRM","IE00BJTD4N35.SGD","IE00BQXX3D17.EUR","LU0820561818.USD","LU0251131958.USD","LU0630314457.HKD","AGMI","EYES","LU0198837287.USD","SLVP","PLT","PLYY","BK4125","LU0648000940.SGD","LU2125909759.SGD","LU1923623000.USD","LU0310799852.SGD","LU2462611646.USD","PSKY","LU1267930227.SGD","LU0345780521.USD","LU0477156953.USD","BK4550","IE00BZ9MQY76.HKD","LU0689626769.HKD","LU0528227936.USD","LU0498741114.HKD","LU0251142724.SGD","IE00B894F039.SGD","LU0082616367.USD","LU2381873111.SGD","LU0368265764.SGD","AUAU","LU0477156797.USD","LU1316542783.SGD","LU0889565833.HKD","IE00BQXX3F31.USD","PTIR","SNDG","TMSL","GDMN","LU0234570918.USD","LU2360107168.USD","LU0234572021.USD","LU1989772840.SGD","LU0154245673.USD","BK4097","LU0052756011.USD","LU0054578231.USD","LU0069063385.USD","TRUM","IE00B19Z3581.USD","LU1548497426.USD","LU0708995401.HKD","LU1861215975.USD","BK4567","LU1323610961.USD","IE00B19Z9Z06.USD","WDNA","MRNA","LU2089284900.SGD","LU0498741890.SGD","LU1223083913.SGD","BK4543","LU0075056555.USD","LU2362540622.SGD","LU2290526834.HKD","LU1804176565.USD","LU0612318971.USD","LU0354030438.USD","LU0654597011.USD","PLTL","LU1791710400.SGD","LU2458330243.SGD","LU0266013472.USD","LU2028103732.USD","LU0266512127.USD","LU1201861165.SGD","LU0106261372.USD","LU0943347566.SGD","LU1116320901.HKD","LU0456854461.SGD","LU2458330169.SGD","IT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU2456880835.USD","LU1035775433.USD","BK4139","LU1430594728.SGD","ACKY","LU1069344957.HKD","LU0417517546.SGD","IE0002141913.USD","BRKC","GNMX","LU0061475181.USD","BK4588","IDNA","IE00BFTCPJ56.SGD","BRKD","LU1674673428.USD","LU1559883803.SGD","VRTX","BIB","LU2468319806.SGD","IBB","IBBQ","LU0320765992.SGD","LU0109394709.USD","VERX","BRKU","LU2362541513.USD","TBXU","IE00BZ9MQY76.HKD","BBH","LU0757428866.USD","BK4567","BRKW","LU0234570918.USD","SG9999001176.USD","ACTV","IE00BJJMRZ35.SGD","LU0058720904.USD","IE00B19Z9P08.USD","LU0889565916.HKD","LU2237438978.USD","LU1585245621.USD","LU2462157665.USD","BRKL","IE00BJT1NW94.SGD","LU0256863811.USD","LU1778281490.HKD","IE00B2B36J28.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1559883803.SGD","IE00BJJMRZ35.SGD","GNMX","IE00B19Z3B42.SGD","BBH","LU1430594728.SGD","BK4139","LU0079474960.USD","IBBQ","LU0289739699.SGD","LU1815336091.USD","LU2362540622.SGD","SG9999001176.USD","LU2089984988.USD","BK4588","TSPA","VRTX","TBXU","PBE","LU0109394709.USD","LU1069344957.HKD","BK4532","IBB","LU0823416689.USD","SG9999001176.SGD","BIB","VERX","LU0061475181.USD","LU2417539215.USD","LU0432979614.USD","BK4585","LU1035775433.USD","LU1674673428.USD","IE0002141913.USD","IE00B19Z9Z06.USD","LU0234570918.USD","SGXZ57979304.SGD","LU1778281490.HKD","LU2324357040.USD","LU1674673691.USD","IE00BZ9MQY76.HKD","IDNA","TACU","CDIG","LU0566484027.USD","LU0889565916.HKD","LU1093756168.USD","IE0009355771.USD","IE00B19Z3581.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881893","title":"Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881893","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881893?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:30","pubTimestamp":1788219000,"startTime":"0","endTime":"0","summary":"An Important Step Forward for Access to LEQEMBI for Eligible Patients in CanadaTOKYO and CAMBRIDGE, Mass., Aug.  31, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/31/3353756/0/en/canada-s-drug-agency-issues-final-positive-recommendation-supporting-public-reimbursement-of-leqembi-lecanemab-for-early-alzheimer-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","IDNA","NVIB","SOCL","MCI","GDOC","HYLG","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883783","title":"Incyte Reaches CMS Pact on Jakafi Medicaid Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883783","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883783?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:47","pubTimestamp":1788209252,"startTime":"0","endTime":"0","summary":"An announcement from Incyte ( ($INCY) ) is now available. Incyte Corporation said it has entered into an agreement with the U.S. Centers for Medica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","IDNA","RSPH","BK4139","BK4585","BK4588","INCY","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883188","title":"NeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-210","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883188?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:37","pubTimestamp":1788208671,"startTime":"0","endTime":"0","summary":"NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an update. NeuroThera Labs reported strong enrollment momentum in its SCI-210 clinical trial for ch...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-advances-enrollment-in-autism-drug-trial-for-sci-210?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-advances-enrollment-in-autism-drug-trial-for-sci-210?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","GDOC","HYLG","IDNA","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883375","title":"Incyte - Expects Exemption from Future CMS Pricing Mandates Including Guard and Globe - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883375?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INCY","BK4532","BK4550","IDNA","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":1,"totalSize":323,"code":"91000000","status":"200"}]}}